CA Patent

CA2455598A1 — Lipid constructs as therapeutic and imaging agents

Assigned to Targesome Inc · Expires 2003-02-13 · 23y expired

What this patent protects

Lipid constructs containing a chelator, a targeting entity, a detectable entity, and/or a therapeutic entity are provided, as well as methods relatin g to their use. The therapeutic or treatment entity may be associated with the lipid construct by covalent or non-covalent means. …

USPTO Abstract

Lipid constructs containing a chelator, a targeting entity, a detectable entity, and/or a therapeutic entity are provided, as well as methods relatin g to their use. The therapeutic or treatment entity may be associated with the lipid construct by covalent or non-covalent means. In some cases, the therapeutic or treatment entity is a radioisotope.

Drugs covered by this patent

Patent Metadata

Patent number
CA2455598A1
Jurisdiction
CA
Classification
Expires
2003-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Targesome Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.